Elisma Schoeman

Survival and health of children who are HIV-exposed uninfected: study protocol for the CHERISH (Children HIV-Exposed Uninfected - Research to Inform Survival and Health) dynamic, prospective, maternal-child cohort study

L. Myer, M. Cotton, M. Tomlinson, 2023, BMJ Open.

First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults.

M. Tameris, M. Hatherill, T. Scriba, 2015, Vaccine.

Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial.

S. Madhi, A. Gutschmidt, M. Tameris, 2022, The Lancet. Infectious diseases.

Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study

Richard G. White, A. Fiore-Gartland, M. Tameris, 2021, The Lancet. Global health.

Mitigating Infectious morbidity and Growth deficits in HIV-exposed uninfected infanTs with human Milk Oligosaccharide (MIGH-T MO): a randomised trial protocol

G. Aldrovandi, R. Shivakoti, L. Bode, 2022, BMJ Open.

Feasibility Study of a Powder-Based Supplement Intervention for a future Synbiotic Trial in Breastfed Children from South Africa

G. Aldrovandi, R. Shivakoti, L. Bode, 2023, Research square.

Multidimensional analyses reveal modulation of adaptive and innate immune subsets by tuberculosis vaccines

S. Omarjee, Greg Finak, S. Gurunathan, 2020, Communications Biology.